Advanced search
1 file | 2.00 MB

Lymphocyte labeling with technetium-99M-HPPAO : a radiotoxicity study using the micronucleus assay

(1992) JOURNAL OF NUCLEAR MEDICINE. 33(6). p.1167-1174
Author
Organization
Abstract
The cytogenetic radiation damage to lymphocytes after in-vitro labeling of mixed leukocytes and isolated lymphocytes with Tc-99m-hexamethylpropyleneamine oxime (HMPAO) was evaluated using the cytokinesis-blocked micronucleus assay. A direct assessment of the radiation damage to the lymphocytes after a labeling procedure of leukocytes separated from 46 ml blood with 740 MBq of Tc-99m-HMPAO was not possible due to an almost complete impairment of the proliferative capacity. By starting with isolated lymphocytes, the number of micronuclei was studied versus the intracellular activity concentration in the range 0-3 MBq/10(7) lymphocytes for three donors. A comparison of these results with the dose response of the micronucleus incidence in lymphocytes after in-vitro irradiation with x-rays allowed an individual assessment of the x-ray dose, inducing the equivalent amount of clastogenic damage as the intracellular activity after Tc-99m-HMPAO labeling. Based on an extrapolation of these data, the radiation damage of the lymphocytes due to self-irradiation in a labeling procedure of leukocytes with 740 MBq of Tc-99m-HMPAO was estimated to be equivalent to 26 Gy of x-rays. Due to the observed almost complete inhibition of the proliferative capacity at this high dose level, the increased risk for a lymphoid malignancy after administration of isolated lymphocytes or mixed leukocytes labeled with Tc-99m-HMPAO activities sufficient for scintigraphy can be regarded as small.
Keywords
CELL, GRANULOCYTES, IN-111, INVITRO, LEUKOCYTES, TC-99M, IRRADIATION, DOSIMETRY

Downloads

    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.00 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Thierens, Hubert, Anne Vral, Jean P Van Haelst, Christophe Van De Wiele, Karel HG Schelstraete, and Leo De Ridder. 1992. “Lymphocyte Labeling with technetium-99M-HPPAO : a Radiotoxicity Study Using the Micronucleus Assay.” Journal of Nuclear Medicine 33 (6): 1167–1174.
APA
Thierens, H., Vral, A., Van Haelst, J. P., Van De Wiele, C., Schelstraete, K. H., & De Ridder, L. (1992). Lymphocyte labeling with technetium-99M-HPPAO : a radiotoxicity study using the micronucleus assay. JOURNAL OF NUCLEAR MEDICINE, 33(6), 1167–1174.
Vancouver
1.
Thierens H, Vral A, Van Haelst JP, Van De Wiele C, Schelstraete KH, De Ridder L. Lymphocyte labeling with technetium-99M-HPPAO : a radiotoxicity study using the micronucleus assay. JOURNAL OF NUCLEAR MEDICINE. 1992;33(6):1167–74.
MLA
Thierens, Hubert, Anne Vral, Jean P Van Haelst, et al. “Lymphocyte Labeling with technetium-99M-HPPAO : a Radiotoxicity Study Using the Micronucleus Assay.” JOURNAL OF NUCLEAR MEDICINE 33.6 (1992): 1167–1174. Print.
@article{224499,
  abstract     = {The cytogenetic radiation damage to lymphocytes after in-vitro labeling of mixed leukocytes and isolated lymphocytes with Tc-99m-hexamethylpropyleneamine oxime (HMPAO) was evaluated using the cytokinesis-blocked micronucleus assay. A direct assessment of the radiation damage to the lymphocytes after a labeling procedure of leukocytes separated from 46 ml blood with 740 MBq of Tc-99m-HMPAO was not possible due to an almost complete impairment of the proliferative capacity. By starting with isolated lymphocytes, the number of micronuclei was studied versus the intracellular activity concentration in the range 0-3 MBq/10(7) lymphocytes for three donors. A comparison of these results with the dose response of the micronucleus incidence in lymphocytes after in-vitro irradiation with x-rays allowed an individual assessment of the x-ray dose, inducing the equivalent amount of clastogenic damage as the intracellular activity after Tc-99m-HMPAO labeling. Based on an extrapolation of these data, the radiation damage of the lymphocytes due to self-irradiation in a labeling procedure of leukocytes with 740 MBq of Tc-99m-HMPAO was estimated to be equivalent to 26 Gy of x-rays. Due to the observed almost complete inhibition of the proliferative capacity at this high dose level, the increased risk for a lymphoid malignancy after administration of isolated lymphocytes or mixed leukocytes labeled with Tc-99m-HMPAO activities sufficient for scintigraphy can be regarded as small.},
  author       = {Thierens, Hubert and Vral, Anne and Van Haelst, Jean P and Van De Wiele, Christophe and Schelstraete, Karel HG and De Ridder, Leo},
  issn         = {0161-5505},
  journal      = {JOURNAL OF NUCLEAR MEDICINE},
  keyword      = {CELL,GRANULOCYTES,IN-111,INVITRO,LEUKOCYTES,TC-99M,IRRADIATION,DOSIMETRY},
  language     = {eng},
  number       = {6},
  pages        = {1167--1174},
  title        = {Lymphocyte labeling with technetium-99M-HPPAO : a radiotoxicity study using the micronucleus assay},
  url          = {http://jnm.snmjournals.org/content/33/6/1167},
  volume       = {33},
  year         = {1992},
}